What can CBG do?

What Can CBG Do?

CBG was discovered around 60 years ago, but only now are scientists and supporters starting to see the full potential of this Cannabinoid. According to a Forbes article from Sept 2019, the NCCIH (National Center for Complementary and Integrative Health USA) announced they would be researching CBG and other Cannabinoids to see how they could help consumers with pain management. John Huemueller, CEO of ACIM Biotechnologies, was quoted in the Forbes article stating

“We know that CBG shows promise as an antibacterial agent and an anti-inflammatory. The potential health benefits of CBG are extensive. A non-intoxicating compound, it’s thought to help regulate mood thanks to its ability to boost Anandamide, the body’s native ‘bliss’ molecule, as well as GABA reuptake. CBG is also a potent neuroprotectant and is currently being evaluated for its ability to combat ailments like Huntingdon’s Disease. It also has cancer fighting properties and is a potent antibacterial that can even treat MRSA”

CBG has been found to act on very specific physiological systems and problems, and results for medicinal use are promising

Endocannabinoid receptors are prevalent in eye structures, and interestingly, CBG is thought to be particularly effective in treating Glaucoma because it reduces Intraocular Pressure. It is a powerful vasodilator and has neuroprotective effects to boot.
In animal experiments involving mice, CBG was found to be effective in decreasing the inflammation characteristic of IBD (Inflammatory Bowel Disease).
In a 2015 study, CBG was shown to protect neurons in mice with Huntingdon’s Disease, which is characterized by nerve cell degeneration in the brain.
CBG is showing great promise as a cancer fighter. Specifically, CBG was shown to block receptors that cause cancer cell growth. In one such study it was shown to inhibit the growth of colorectal cancer cells in mice, thereby slowing colon cancer growth. CBG inhibited tumours and chemically induced colon carcinogens, therefore demonstrating a very exciting possibility for a cure for colorectal cancer.
European research shows evidence that CBG is an effective antibacterial agent, particularly against methicillin resistant Staphylococcus Aureus (MRSA), microbial strains resistant to several classes of drugs. Since the 1950’s, topical formations of cannabis have been effective in skin infections, but researchers at the time were unaware of the plants chemical composition.
In a recent 2017 study, researchers showed that a form of CBG purified to remove delta-9 THC was a highly effective appetite stimulant in rats. This may lead to a novel non-psychotropic therapeutic option for cachexia; the muscle wasting, and severe weight loss seen in late stage cancer and other diseases
In a study that looked at the effects of five different Cannabinoids on bladder contractions, CBG tested best at inhibiting muscle contractions, so it may be a future tool in preventing bladder dysfunction disorders.

Scientists are excited about these initial CBG results and are promoting future research with CBG alone, or CBG in combination with other Cannabinoids and therapies for the treatment of multiple maladies. Because it is non psychotropic, CBG has a promising wide range of potential applications, not only for the problems mentioned above, but also an analgesic, therapy for Psoriasis, and as an antidepressant.